2025 Senate Bill 94

Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit.

A bill to amend 1978 PA 368, entitled “Public health code,” (MCL 333.1101 to 333.25211) by adding section 17757c.

Official record

AI Analysis – Experimental

Senate Bills 94 and 95 amend the Public Health Code to regulate 340B drug distribution, requiring annual reports from 340B entities and manufacturers on drug costs and compliance.

Introduced in the Senate

Feb. 20, 2025

Introduced by Sen. Sam Singh (D-28) and eight co-sponsors

Co-sponsored by Sens. Joseph Bellino (R-16), Jonathan Lindsey (R-17), John Damoose (R-37), Rick Outman (R-33), Sue Shink (D-14), Stephanie Chang (D-3), Mallory McMorrow (D-8) and Kevin Hertel (D-12)

Referred to the Committee on Oversight

Feb. 27, 2025

Reported without amendment

March 5, 2025

Referred to the Committee of the Whole

Reported without amendment

March 6, 2025

Passed in the Senate 33 to 3 (details)

Received in the House

March 6, 2025

Referred to the Committee on Health Policy